↓ Skip to main content

Interleukin 32: a novel player in the control of infectious diseases

Overview of attention for article published in Journal of Leukocyte Biology, October 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter
4 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
60 Dimensions

Readers on

mendeley
65 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Interleukin 32: a novel player in the control of infectious diseases
Published in
Journal of Leukocyte Biology, October 2016
DOI 10.1189/jlb.4ru0416-175rr
Pubmed ID
Authors

Fátima Ribeiro‐Dias, Rodrigo Saar Gomes, Lucas Luiz de Lima Silva, Jéssica Cristina dos Santos, Leo A. B. Joosten

Abstract

Interleukin 32 (IL-32) is a proinflammatory cytokine, expressed as 9 distinct isoforms. The most active isoform is the predominantly intracellular-functioning IL-32γ. Involvement of IL-32 in infectious diseases is increasingly being appreciated. Production of IL-32 promotes pathways that serve to control bacterial infection, especially those caused by mycobacteria. A similar role for this cytokine is observed in the cellular response to viral infections. In addition to its protective effects against microorganisms, IL-32 is involved in immunopathogenesis of some infectious diseases. In parasitic diseases, it has been demonstrated that this cytokine is induced by Leishmania infection. In this review, we summarize the present data on the role of IL-32 in infectious diseases, highlighting this cytokine as new target for control of infections.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 65 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 14 22%
Researcher 13 20%
Student > Ph. D. Student 7 11%
Student > Bachelor 6 9%
Other 3 5%
Other 6 9%
Unknown 16 25%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 15 23%
Immunology and Microbiology 13 20%
Medicine and Dentistry 8 12%
Agricultural and Biological Sciences 5 8%
Nursing and Health Professions 2 3%
Other 5 8%
Unknown 17 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 January 2020.
All research outputs
#5,626,248
of 22,896,955 outputs
Outputs from Journal of Leukocyte Biology
#880
of 4,051 outputs
Outputs of similar age
#85,453
of 313,742 outputs
Outputs of similar age from Journal of Leukocyte Biology
#7
of 35 outputs
Altmetric has tracked 22,896,955 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,051 research outputs from this source. They receive a mean Attention Score of 5.0. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 313,742 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.